JNJ - JOHNSON & JOHNSON
162.3
-0.610 -0.376%
Share volume: 12,546,930
Last Updated: Fri 21 Feb 2025 10:00:00 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.42%
PREVIOUS CLOSE
CHG
CHG%
$162.91
2.62
0.02%
Fundamental analysis
53%
Profitability
60%
Dept financing
36%
Liquidity
67%
Performance
46%
Performance
5 Days
4.72%
1 Month
10.68%
3 Months
4.19%
6 Months
-1.11%
1 Year
0.28%
2 Year
2.90%
Key data
Stock price
$162.30
DAY RANGE
$159.28 - $163.51
52 WEEK RANGE
$140.68 - $168.85
52 WEEK CHANGE
$0.94
DIVIDEND
$1.24
EX-DIVIDEND DATE
02/18/2025
NEXT EARNINGS DATE
N/A
Company detail
CEO: Joaquin Duato
Region: US
Website: jnj.com
Employees: 152,700
IPO year: 1970
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: jnj.com
Employees: 152,700
IPO year: 1970
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands. Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis. MedTech segment provides electrophysiology products to treat cardiovascular diseases.
Recent news